I was just listening to an bio-pharma analyst on bloomberg radio in New York and he said a lot of exciting things are happening at Neoprobe and he said the stock was a strong buy and put a $7.50 six-month price target on it. I don't have a link yet. bloomberg sometimes posts it on their website later in the day. sometimes they don't. if they do I will post it. this has AMRN all over it. good luck
As someone else has posted, Uri from Platinum (one of Neoprobe's top advocates), was on Pimm Fox's show talking about Echo Therapeutics. Do you recall if he's the person that mentioned Neoprobe (he doesn't mention Neoprobe in the podcast that is posted)?